Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-06

FDA Approved: KAITLIB FE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for KAITLIB FE (norethindrone and ethinyl estradiol) from Lupin Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KAITLIB FE (Norethindrone and Ethinyl Estradiol)

Snippet

SUPPL AP for KAITLIB FE (NORETHINDRONE AND ETHINYL ESTRADIOL)